Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute for Clinical Genetics, |
RCV003237619 | SCV002011003 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003464132 | SCV004206752 | uncertain significance | Palmoplantar keratoderma-esophageal carcinoma syndrome | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003237619 | SCV005690808 | uncertain significance | not provided | 2024-03-20 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 575 of the RHBDF2 protein (p.Pro575Leu). This variant is present in population databases (rs756654862, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with RHBDF2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1319626). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |